Is it time to replace BASDAI with ASDAS?
Descrição
New Horizons in TNF Inhibition - Topic 1: Treating Ankylosing
Responsiveness of a simple RAPID-3-like index compared to disease
BASDAI & ASDAS Calculator
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor
Sustained clinical response and safety of etanercept in patients
Construct validity and responsiveness of the simplified version of
Construct validity and responsiveness of the simplified version of
PDF) Is ASDAS better than BASDAI as a measure of disease activity
Comparative effectiveness of secukinumab and adalimumab in
Achievement of Remission Endpoints with Secukinumab Over 3 Years
Disease Activity and Clinical Response Early in the Course of
Assessment and Monitoring, Ankylosing Spondylitis
New Horizons in TNF Inhibition - Topic 1: Treating Ankylosing
de
por adulto (o preço varia de acordo com o tamanho do grupo)
